Trial Profile
To compare the doses of Suggammadex in patients with deep neuromuscular blockade
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2017
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 29 Mar 2017 New trial record